Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Astrana Health, Inc. (ASTH) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$654.81M
Net Income	$9.42M
Cost of Goods Sold	$576.84M
Gross Profit	$77.97M
Operating Expenses	$634.47M
Operating Income	$20.34M
Non-Operating Income/Expense	$-3.52M
Pre-Tax Income	$16.82M
Normalized Pre-Tax Income	$16.81M
Income after Taxes	$10.22M
Income from Continuous Operations	$10.22M
Consolidated Net Income/Loss	$10.22M
Normalized Income after Taxes	$10.20M
EBIT	$20.34M
EBITDA	$28.29M
Weighted-Average Shares Outstanding (Basic)	49.19M
Weighted-Average Shares Outstanding (Diluted)	49.47M
Earnings per Share (EPS) (Basic)	$0.19
Earnings per Share (EPS) (Diluted)	$0.19
Balance Sheet Financials
Current Assets	$729.15M
Property, Plant, and Equipment	$17.80M
Long-Term Assets	$713.20M
Total Assets	$1.44B
Current Liabilities	$459.75M
Long-Term Debt	$401.06M
Long-Term Liabilities	$211.08M
Total Liabilities	$670.82M
Common Equity	$771.53M
Tangible Shareholders Equity	$248.87M
Shareholders Equity	$771.53M
Common Shares Outstanding	49.14M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$107.53M
Cash Flow from Investing Activities	$-3.47M
Cash Flow from Financial Activities	$-52.81M
Beginning Cash	$289.10M
End Cash	$340.35M
Increase/Decrease in Cash	$51.25M
Stock-Based Compensation	$19.52M
Common Stock Dividends Paid	$-6.23M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.59
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.34
Debt to Equity Ratio	0.54
Gross Margin	11.91%
Operating Margin	3.11%
EBIT Margin	3.11%
EBITDA Margin	--
Pre-Tax Profit Margin	2.57%
Profit Margin	1.44%
Free Cash Flow	$103.04M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.45
Inventory Turnover	--
Receiveable Turnover	1.79
Days Sales in Receivables	50.21
Return on Equity	1.32%
Return on Tangible Equity	4.10%
Return on Assets	0.71%
Return on Investments	0.87%
Book Value Per Share	$15.70
Free Cash Flow per Share	$2.08
Operating Cash Flow per Share	$2.17

Data from Zacks Investment Research, Inc.